Stemina Biomarker Discovery, Inc., today announced study results showing the high performance of the company’s Cardio quickPredict test in identifying cardiotoxic effects for a large number of well-characterized drugs....
Dianomi previously licensed its core technology, the mineral coated microparticles, from WARF, UW-Madison's tech-transfer arm. The new license expands the technology's use to nucleic acid therapy — using DNA or RNA, or related compounds, to modify or enhance the expression of desired genes....
Cancer diagnostics company Exact Sciences Corp. has more than doubled the capital investment and job creation numbers it proposed under an agreement with the Wisconsin Economic Development Corp., according to documents obtained by the Milwaukee Business Journal per a public records request....
Exact Sciences brought in about $230 million in screening revenue during the fourth quarter of last year, according to the company’s latest preliminary financial report....
A $267 million stock offering last week by Arrowhead Pharmaceuticals, which has its main employment base in Madison, could help the company bring experimental drugs to market and lead to the purchase of other businesses....
Exact Sciences announced Dr. David Ahlquist, co-inventor of Cologuard® has been named a Fellow of the National Academy of Inventors (NAI)....
The state Legislature has passed several bills championed by the Wisconsin Technology Council that would change state laws surrounding startup funding and oversight. ...
Even before current construction is finished, Exact Sciences is planning for another stage of expansion at one of its Madison campuses, which could about double its lab space....
Eighteen state startups took to the stage to pitch their companies during lightning rounds at the Elevator Pitch Olympics in Madison. The annual competition was part of the Wisconsin Early Stage Symposium, a two-day event put on by the Wisconsin Technology Council....
Invenra Inc., a Madison startup that developed a drug discovery platform to identify human multi-specific antibodies for immuno-oncology, is one of the four startups to receive an investment from Wisconsin's Venture Investors....